within Pharmacolibrary.Drugs.ATC.R;

model R06AX13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.1545,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.119,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.017166666666666667,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Loratadine is a second-generation, non-sedating antihistamine used to relieve symptoms of allergy such as sneezing, runny nose, and itchy eyes. It is commonly prescribed for the treatment of allergic rhinitis and urticaria, and is approved for use in many countries worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both male and female, following single oral dose.</p><h4>References</h4><ol><li><p>Islam, N, et al., &amp; Ni, J (2023). Loratadine oral bioavailability enhancement via solid dispersion loaded oro-dispersible films: Formulation, characterization and pharmacokinetics. <i>Colloids and surfaces. B, Biointerfaces</i> 230 113526–None. DOI:<a href=&quot;https://doi.org/10.1016/j.colsurfb.2023.113526&quot;>10.1016/j.colsurfb.2023.113526</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37647750/&quot;>https://pubmed.ncbi.nlm.nih.gov/37647750</a></p></li><li><p>Li, C, et al., &amp; Choi, JS (2008). Effects of roxithromycin on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats. <i>European journal of drug metabolism and pharmacokinetics</i> 33(4) 231–236. DOI:<a href=&quot;https://doi.org/10.1007/BF03190877&quot;>10.1007/BF03190877</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19230596/&quot;>https://pubmed.ncbi.nlm.nih.gov/19230596</a></p></li><li><p>Li, C, et al., &amp; Choi, JS (2010). Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats. <i>Archives of pharmacal research</i> 33(9) 1395–1400. DOI:<a href=&quot;https://doi.org/10.1007/s12272-010-0913-y&quot;>10.1007/s12272-010-0913-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20945138/&quot;>https://pubmed.ncbi.nlm.nih.gov/20945138</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R06AX13;
